Scilex Pharmaceuticals Revenue and Competitors

Location

$7.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Scilex Pharmaceuticals's estimated annual revenue is currently $21.1M per year.(i)
  • Scilex Pharmaceuticals's estimated revenue per employee is $201,000
  • Scilex Pharmaceuticals's total funding is $7.5M.

Employee Data

  • Scilex Pharmaceuticals has 105 Employees.(i)
  • Scilex Pharmaceuticals grew their employee count by 8% last year.

Scilex Pharmaceuticals's People

NameTitleEmail/Phone
1
Chief Medical Officer & SVPReveal Email/Phone
2
Territory Business ManagerReveal Email/Phone
3
Territory Business ManagerReveal Email/Phone
4
Territory Business ManagerReveal Email/Phone
5
Territory Business ManagerReveal Email/Phone
6
Territory Business ManagerReveal Email/Phone
7
Territory Business ManagerReveal Email/Phone
8
Territory Business ManagerReveal Email/Phone
9
Territory Business ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Scilex Pharmaceuticals?

Scilex, a majority-owned subsidiary of Sorrento located in San Diego, California, responsibly develops and brings branded pharmaceutical products to market using technologies designed to maximize quality of life. We are uncompromising in our focus to become the global pharmaceutical leader committed to social, environmental, economic, and ethical principles. Dedicated to using international partnerships, we strive to deliver next generation products that are Responsible By Design.

keywords:N/A

$7.5M

Total Funding

105

Number of Employees

$21.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Scilex Pharmaceuticals News

2022-04-19 - Lidocaine Market Recovery and Impact Analysis Report ...

Amneal Pharmaceuticals Inc. AstraZeneca, Teligent, Centura Pharmaceuticals Taro Pharmaceutical Industries Ltd. Pfizer Inc. Merck KGaA. SCILEX...

2022-04-13 - Scilex Holding Company, a majority-owned subsidiary of ...

... an accomplished pharmaceutical and biotechnology executive, to its Board of Directors. Ms. Hamill brings to the Scilex board more than...

2022-03-30 - Sorrento Reports FDA Clearance for the Commencement of a ...

ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc. All other trademarks are the property of their respective owners.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.6M1066%N/A
#2
$33.9M1109%N/A
#3
$35.1M1302%N/A
#4
$35.6M132-35%N/A
#5
$40M1385%N/A